Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    LETROF L LIL

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,902Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Axplora
    Germany
    		 Novartis Korea Co., Ltd. 20210910-209-J-1104 letrozole 2021-09-10 FINORGA SAS@Jetpharma SA Germany route de Givors Chasse Sur Rhone,38670, France@Via Sottobisio 42A, 6828 Balerna,Switzerland
    29/11/2025 Jiangsu Hengrui Medicine
    China
    		 Hwail Pharmaceutical Co., Ltd. 20191001-209-J-211 letrozole 2019-10-01 Jiangsu Hengrui Pharmaceuticals Co., Ltd China 22 Jinqiao Road, Dapu Industrial Park, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China